This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Peer Reviewed Publication Supporting Intravenous Vitamin C For Cancer Patients

"We are proud to have had such a multi-disciplinary collaboration as part of this team including scientists/doctors from University of Western Ontario, Canada, the Torrey Pines Research Institute, the University of Puerto Rico, University of Connecticut, University of Nebraska Medical Center, University of Latvia, the Lawson Health Research Institute, and Loma Linda University," stated Brian Riordan, CEO of the Riordan Clinic.  "The Riordan Clinic ( www.riordanclinic.org) has been using intravenous vitamin C for decades; my personal mission is to seek input from colleagues in conventional oncology in order to figure out how we can collectively generate best treatment methods for our patients.  This paper is a small step in what we anticipate will be many successful collaborations with our friends in conventional oncology practice." Funding for the publication was provided by Allan P. Markin's Pure North S'Energy Foundation.

The Riordan Clinic is a progressive nutrition-based medical clinic located in Wichita, Kansas founded by Hugh D. Riordan, M.D. and Olive W. Garvey. For 35 years, the Riordan Clinic has integrated lifestyle and nutrition to help patients find the underlying causes of their illness. Since the inception in 1975, the mission has been clear and unwavering to "…stimulate an epidemic of health."

SOURCE Bio-Communications Research Institute

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs